Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
370.20
307.17
251.03
456.19
262.01
139.30
166.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
370.20
307.17
251.03
456.19
262.01
139.30
166.29
Raw Material Cost
165.41
153.81
113.22
199.31
165.28
91.92
114.06
Purchase of Finished goods
15.90
0.85
0.04
3.80
0.22
0.67
0.13
(Increase) / Decrease In Stocks
1.17
-1.48
-3.20
-2.51
0.09
-5.51
5.25
Employee Cost
43.78
32.56
29.96
20.15
15.90
11.93
8.56
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
63.54
55.12
50.86
63.77
51.68
26.10
22.58
Total Expenditure (Excl Depreciation)
289.81
240.86
190.89
284.52
233.17
125.11
150.59
Operating Profit (PBDIT) excl Other Income
80.39
66.31
60.14
171.67
28.84
14.19
15.70
Other Income
1.92
1.83
2.94
3.51
1.59
3.66
0.61
Operating Profit (PBDIT)
82.31
68.14
63.08
175.18
30.43
17.85
16.31
Interest
9.88
10.39
6.02
2.92
2.67
2.50
2.28
Exceptional Items
0.00
-7.10
-16.53
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
72.43
50.65
40.53
172.26
27.76
15.35
14.03
Depreciation
18.29
19.56
14.96
10.69
6.49
4.43
3.12
Profit Before Tax
54.14
31.10
25.57
161.57
21.27
10.92
10.91
Tax
14.34
7.48
6.29
41.63
6.38
2.71
3.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
39.80
23.62
19.28
119.94
14.89
8.21
7.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
39.80
23.62
19.28
119.94
14.89
8.21
7.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.04
0.18
0.09
0.05
0.26
0.11
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.85
23.80
19.37
119.99
15.15
8.32
7.55
Equity Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
252.87
213.04
189.34
170.77
50.78
35.63
26.92
Earnings per share (EPS)
38.39
22.93
18.66
115.6
14.6
8.02
7.27
Diluted Earnings per share
38.36
22.76
18.16
115.64
14.6
8.02
7.28
Operating Profit Margin (Excl OI)
21.72%
21.59%
23.96%
37.63%
11.01%
10.19%
9.44%
Gross Profit Margin
19.57%
16.49%
16.15%
37.76%
10.6%
11.02%
8.44%
PAT Margin
10.75%
7.69%
7.68%
26.29%
5.68%
5.89%
4.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 20.52% vs 22.36% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 67.44% vs 22.87% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.23% vs 10.26% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -4.91% vs 72.59% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Kwality Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
370.20
405.51
-35.31
-8.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
370.20
405.51
-35.31
-8.71%
Raw Material Cost
165.41
76.31
89.10
116.76%
Purchase of Finished goods
15.90
73.67
-57.77
-78.42%
(Increase) / Decrease In Stocks
1.17
-17.98
19.15
106.51%
Employee Cost
43.78
96.38
-52.60
-54.58%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.02
200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
63.54
128.09
-64.55
-50.39%
Total Expenditure (Excl Depreciation)
289.81
356.46
-66.65
-18.70%
Operating Profit (PBDIT) excl Other Income
80.39
49.05
31.34
63.89%
Other Income
1.92
4.67
-2.75
-58.89%
Operating Profit (PBDIT)
82.31
53.72
28.59
53.22%
Interest
9.88
10.04
-0.16
-1.59%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
72.43
43.68
28.75
65.82%
Depreciation
18.29
9.93
8.36
84.19%
Profit Before Tax
54.14
33.74
20.40
60.46%
Tax
14.34
9.84
4.50
45.73%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
39.80
23.90
15.90
66.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
39.80
23.90
15.90
66.53%
Share in Profit of Associates
0.00
5.93
-5.93
-100.00%
Minority Interest
0.04
0.00
0.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.85
29.83
10.02
33.59%
Equity Capital
10.38
9.20
1.18
12.83%
Face Value
10.00
1.00
0.00
Reserves
252.87
360.43
-107.56
-29.84%
Earnings per share (EPS)
38.39
3.24
35.15
1,084.88%
Diluted Earnings per share
38.36
3.24
35.12
1,083.95%
Operating Profit Margin (Excl OI)
21.72%
12.10%
0.00
9.62%
Gross Profit Margin
19.57%
10.77%
0.00
8.80%
PAT Margin
10.75%
7.36%
0.00
3.39%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 370.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.52% vs 22.36% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 39.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 67.44% vs 22.87% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 80.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.23% vs 10.26% in Mar 2024
Annual - Interest
Interest 9.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -4.91% vs 72.59% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.72%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
